Cinnarizine + Dimenhydrinate
Symtiver contains two active substances: cinnarizine and dimenhydrinate.
These substances belong to different groups of medicines. Cinnarizine belongs to a group of medicines called calcium antagonists. Dimenhydrinate belongs to a group of antihistamine medicines.
Both substances reduce the symptoms of dizziness (feeling of dizziness or "spinning") and nausea. If both substances are taken at the same time, they work more effectively than when taken separately.
Symtiver is used in adults to treat dizziness of various origins. There may be different causes of dizziness. Taking Symtiver can help with daily activities that are difficult due to dizziness.
Before taking Symtiver, discuss it with your doctor or pharmacist if you have:
Taking Symtiver may worsen your condition. Symtiver may still be suitable for you, but your doctor must consider the above factors.
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, as well as any medicines you plan to take.
Symtiver may interact with other medicines you are taking.
If Symtiver is taken with the following medicines, it may cause drowsiness or sleepiness:
Symtiver may enhance the effects of the following medicines:
Aminoglycosides (a type of antibiotic) can damage the inner ear. When taking Symtiver, such damage may go unnoticed.
Do not take Symtiver with medicines used to treat irregular heart rhythms (antiarrhythmic medicines). Additionally, Symtiver may change skin reactions to allergens during skin tests.
Symtiver may cause indigestion. This can be reduced by taking the tablets after a meal. Do not drink alcohol while taking Symtiver, as it may cause drowsiness and sleepiness.
Do not take Symtiver if you are pregnant or breastfeeding, or think you may be pregnant.
Symtiver may cause sleepiness. If this occurs, do not drive or operate machinery.
This medicinal product contains less than 1 mmol of sodium (23 mg) per tablet, which means it is essentially "sodium-free".
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
The recommended dose of Symtiver is: 1 tablet taken three times a day after a meal and swallowed with a liquid. The tablet should be swallowed whole without chewing. Symtiver is usually taken for up to 4 weeks.
Your doctor will tell you if it is necessary to extend the treatment period with Symtiver.
If you accidentally take more tablets than recommended or if a child swallows some tablets, contact your doctor immediately.
If you take too much Symtiver, you may experience extreme drowsiness, dizziness, and seizures. Your pupils may become dilated, and you may have difficulty urinating. You may also experience dry mouth, sudden flushing of the face, increased heart rate, fever, sweating, and headache.
If you take a very high dose of Symtiver, you may experience seizures, hallucinations, high blood pressure, tremors, agitation, and difficulty breathing.
Coma may occur.
If you miss a Symtiver tablet, simply omit it. Take the next Symtiver tablet at the usual time. Do not take a double dose to make up for the missed tablet.
Do not stop taking Symtiver without consulting your doctor. If you stop taking the medicine too early, the symptoms of dizziness (dizziness and "spinning") may return.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, Symtiver can cause side effects, although not everybody gets them.
If you experience infection with fever and significant deterioration of your general condition, tell your doctor and inform them about the medicine you are taking.
Common side effects(may affect up to 1 in 10 people):
Rare side effects(may affect up to 1 in 1,000 people):
Very rare side effects(may affect up to 1 in 10,000 people):
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 30, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after EXP. The expiry date refers to the last day of that month.
There are no special storage instructions for this medicine.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Symtiver is a round, convex, white tablet with a diameter of about 8 mm.
Symtiver is available in packs of 30, 60, 90, or 120 tablets.
Farmak International Sp. z o.o.
ul. Koszykowa 65
00-667 Warsaw
tel.: +48 22 822 93 06
e-mail: biuro@farmakinternational.pl
Atlantic Pharma – Produções Farmacêuticas, S.A.
Rua da Tapada Grande, nº 2, Abrunheira, 2710-089 Sintra, Portugal
Date of last revision of the leaflet:April 2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.